Centre Hospitalier Régional Universitaire de Lille

Lille, Hauts-de-France 59037

0 studies enrolling now · 2 studies all time

What they study most

NASH - Nonalcoholic Steatohepatitis, Primary Biliary Cholangitis

Studies at this site

• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis — Completed